St. Anthony Park resident Michele Chin-Purcell has been named vice president of quality and regulatory affairs at BioSig Technologies.
BioSig is a medical device company with headquarters in Los Angeles and Minneapolis that develops PURE EP, an electrocardiogram and intracardiac multichannel recording and analysis system.
Chin-Purcell has more than 20 years of experience in research, quality and regulatory affairs in the life sciences. Most recently, she served as senior director of regulatory affairs at Spinal Modulation in Menlo Park, Calif. Prior to joining Spinal Modulation, Chin-Purcell served as senior director of regulatory affairs for the atrial fibrillation division of St. Jude Medical in St. Paul. From 2008 to 2010, she was executive director of the Department of Research Integrity and Oversight at the University of Minnesota.
Chin-Purcell received her Ph.D. and master’s degree in mechanical engineering from the University of Minnesota and her bachelor’s in the same discipline from the University of California, Berkley.